📰 Pre Conference Programs News
Pre Conference Programs News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pre Conference Programs. Real-time updates on events, politics, business and more.
July 18, 2023
- ATG-017 is an oral, potent and selective small molecule ERK1/2 inhibitor. Antengene has exclusive global rights to develop, commercialize, and manufacture...
May 11, 2023
Milwaukee, WI (PRWEB) May 11, 2023 -- TheSociety for Immunotherapy of Cancer (SITC) is excited to announce Susan Kaech, PhD, from Salk Institute as the
April 3, 2023
/PRNewswire/ -- Thousands of pediatric researchers, clinical care providers, and leaders in pediatric academics from across the globe will gather in...
November 2, 2022
Milwaukee, WI (PRWEB) November 02, 2022 -- The Society for Immunotherapy of Cancer (SITC) received a record-breaking number of abstract submissions in 2022,
October 20, 2022
/PRNewswire/ -- STORM Therapeutics Ltd. (STORM), the biotechnology company discovering and developing novel small molecule therapies targeting RNA modifying...
October 5, 2022
/PRNewswire/ -- Lytix Biopharma ("Lytix") (Euronext Growth Oslo: LYTIX), a Norwegian immune-oncology company, today announces that an abstract has been...
August 30, 2022
Milwaukee, WI (PRWEB) August 30, 2022 -- The Society for Immunotherapy of Cancer (SITC) is thrilled to announce its 2022 Annual Awards recipients, recognizing
July 14, 2022
Milwaukee, WI (PRWEB) July 14, 2022 -- The Society for Immunotherapy of Cancer (SITC) announces the 2022 class of Fellows of the Academy of Immuno-Oncology
May 19, 2022
Milwaukee, WI (PRWEB) May 19, 2022 -- This year the Society for Immunotherapy of Cancer (SITC) has the pleasure of welcoming Padmanee Sharma, MD, PhD from The
January 13, 2022
Milwaukee, WI (PRWEB) January 12, 2022 -- The Society for Immunotherapy of Cancer (SITC) is pleased to announce the society’s innovative program designed to